Locations:

Research

December 2, 2018/Cancer/Research

Good Response Rate for New Anemia Drug in Patients with Myelodysplastic Syndromes

FDA approval may come in 2019

December 1, 2018/Cancer/Research

Blinatumomab Trial: 66 Percent of Patients Achieve Remission from Acute Lymphoblastic Leukemia

Lower toxicity than conventional chemo

November 14, 2018/Cancer/Research

How Nucleophosmin Mutation Causes Acute Myeloid Leukemia

Groundbreaking study paves way for targeted therapy

October 24, 2018/Cancer/Research

IMmotion Update: Understanding the Biomarkers Behind Better Outcomes

Gene signatures differentiate clinical response

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

October 22, 2018/Cancer/Research

Which Breast Reconstruction Technique Is Best for Patients Undergoing Post-Mastectomy Radiation Therapy?

10-year outcomes favor autologous over implant

October 22, 2018/Cancer/Research

Children with Localized Non-Germinomatous Germ Cell Tumors May Benefit from Reduced-Volume Radiation

Initial study results are encouraging

October 22, 2018/Cancer/Research

Ten-Year Outcomes of Moderately Hypofractionated IMRT in Prostate Cancer

Higher doses don’t mean higher toxicity

October 21, 2018/Cancer/Research

Multi-institutional Study Validates AJCC’s 8th Edition Oral Cavity Cancer Stage System

New system better predicts patient outcomes

October 21, 2018/Cancer/Research

Nomogram Predicts Metastases After SBRT in Non-Small Cell Lung Cancer

May help identify patients for immunotherapy

September 25, 2018/Cancer/Research

Try Ruxolitinib Again When Effectiveness Wanes in Myelofibrosis

Second (or third) time’s a charm in reducing splenomegaly and other symptoms

BackPage 20 of 31Next